Systematic evaluation of the impact of disease progression (DP) date determination on progression-free survival (PFS) in advanced lung cancer: A joint North Central Cancer Treatment Group (NCCTG) and Southwest Oncology Group (SWOG) investigation.
S. J. Mandrekar
No relevant relationships to disclose
Y. Qi
No relevant relationships to disclose
K. Allen-Ziegler
No relevant relationships to disclose
S. L. Hillman
No relevant relationships to disclose
M. W. Redman
No relevant relationships to disclose
S. E. Schild
No relevant relationships to disclose
D. R. Gandara
No relevant relationships to disclose
A. A. Adjei
No relevant relationships to disclose